Sowell Financial Services LLC Alkermes Plc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$18.78 - $25.15 $125,826 - $168,505	-6,700 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$16.16 - $20.66 $355 - $454	-22 Reduced 0.33%	6,700 $111,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $19.41 $65,219 - $95,109	4,900 Added 268.94%	6,722 $130,000
Q1 2020 May 12, 2020	BUY	$13.06 - $21.24 $23,508 - $38,232	1,800 Added 8181.82%	1,822 $26,000
Q4 2019 Feb 07, 2020	SELL	$17.29 - $21.74 $518 - $652	-30 Reduced 57.69%	22 $0
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $1,014 - $1,262	52 New	52 $1,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.